摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-Dihydro-6-(phenylmethoxy)-2-[2-(4-phenyl-1-piperidinyl)ethyl]-1(2H)naphthalenone | 667900-23-4

中文名称
——
中文别名
——
英文名称
3,4-Dihydro-6-(phenylmethoxy)-2-[2-(4-phenyl-1-piperidinyl)ethyl]-1(2H)naphthalenone
英文别名
6-phenylmethoxy-2-[2-(4-phenylpiperidin-1-yl)ethyl]-3,4-dihydro-2H-naphthalen-1-one
3,4-Dihydro-6-(phenylmethoxy)-2-[2-(4-phenyl-1-piperidinyl)ethyl]-1(2H)naphthalenone化学式
CAS
667900-23-4
化学式
C30H33NO2
mdl
——
分子量
439.598
InChiKey
CYZOBDVPCDGVGS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.2
  • 重原子数:
    33
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,4-Dihydro-6-(phenylmethoxy)-2-[2-(4-phenyl-1-piperidinyl)ethyl]-1(2H)naphthalenone 在 palladium on activated charcoal 氢气 作用下, 以 乙醇乙酸乙酯 为溶剂, 以88%的产率得到3,4-Dihydro-6-hydroxy-2-[2-(4-phenyl-1-piperidinyl)ethyl]-1(2H)naphthalenone
    参考文献:
    名称:
    Tetrahydronaphthalene-derived amino alcohols and amino ketones as potent and selective inhibitors of the delayed rectifier potassium current IKs
    摘要:
    Class III anti-arrhythmic drugs (e.g., dofetilide) prolong cardiac action potential duration (APD) by blocking the fast component of the delayed rectifier potassium current (I-Kr). The block of I-Kr can result in life threatening ventricular arrhythmias (i.e., torsades de pointes). Unlike I-Kr, the role of the slow component of the delayed rectifier potassium current (I-Ks) becomes significant only at faster heart rate. Therefore selective blockers Of I-Ks could prolong APD with a reduced propensity to cause proarrhythmic side effects. This report describes structure-activity relationships (SARs) of a series of I-Ks inhibitors derived from 6-alkoxytetralones with good in vitro activity (IC50 > 30 nM) and up to 40-fold I-Ks/I-Kr selectivity. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.10.003
  • 作为产物:
    描述:
    6-羟基-1-四氢萘酮N-甲基吗啉六甲基磷酰三胺氢氧化钾 、 lithium aluminium tetrahydride 、 potassium carbonate 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 戴斯-马丁氧化剂lithium hexamethyldisilazane 作用下, 以 四氢呋喃1,4-二氧六环二氯甲烷N,N-二甲基甲酰胺叔丁醇 为溶剂, 生成 3,4-Dihydro-6-(phenylmethoxy)-2-[2-(4-phenyl-1-piperidinyl)ethyl]-1(2H)naphthalenone
    参考文献:
    名称:
    Tetrahydronaphthalene-derived amino alcohols and amino ketones as potent and selective inhibitors of the delayed rectifier potassium current IKs
    摘要:
    Class III anti-arrhythmic drugs (e.g., dofetilide) prolong cardiac action potential duration (APD) by blocking the fast component of the delayed rectifier potassium current (I-Kr). The block of I-Kr can result in life threatening ventricular arrhythmias (i.e., torsades de pointes). Unlike I-Kr, the role of the slow component of the delayed rectifier potassium current (I-Ks) becomes significant only at faster heart rate. Therefore selective blockers Of I-Ks could prolong APD with a reduced propensity to cause proarrhythmic side effects. This report describes structure-activity relationships (SARs) of a series of I-Ks inhibitors derived from 6-alkoxytetralones with good in vitro activity (IC50 > 30 nM) and up to 40-fold I-Ks/I-Kr selectivity. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.10.003
点击查看最新优质反应信息

文献信息

  • US6048877A
    申请人:——
    公开号:US6048877A
    公开(公告)日:2000-04-11
  • [EN] TETRALONE DERIVATIVES AS ANTIARRHYTHMIC AGENTS<br/>[FR] DERIVES DE TETRALONE UTILISES COMME AGENTS ANTIARYTHMIQUES
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:WO1998036749A1
    公开(公告)日:1998-08-27
    (EN) Tetralone derivatives of formula (I) where R1 is halo, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, (aryl)alkenyl, (aryl)alkynyl, alkoxy, O-alkenyl, O-aryl, O-alkyl(heterocyclo), COO-alkyl, alkanoyl, CO-amino, CO-substituted amino, alkyl-CO-amino, alkyl-CO-substituted amino, NHCO-alkyl, NHCO-aryl, NHCO-alkyl(heterocyclo), N(alkyl)CO-alkyl, N(alkyl)CO-aryl, N(alkyl)CO-heterocyclo, N(alkyl)CO-alkyl(heterocyclo); R2 is hydrogen, alkyl, halo, aryl, alkoxy, amino, substituted amino; R3 is oxo, hydroxy, alkoxy, O-COalkyl, -O-COaryl, -O-COheterocyclo, NOH, NO-alkyl, N-amino, N-substituted amino, N-NHCONHalkyl, N-NHSO2alkyl, N-NHSO2aryl, amino, substituted amino, NHCO-alkyl, NHCO-aryl, NHCO-heterocyclo, spiroheterocyclo; R4 is hydrogen, alkyl, alkyl(COalkyl), alkyl(COOalkyl); or R3 and R4 taken together with the atoms to which they are attached form a five- to seven-membered ring which can contain up to three heteroatoms selected from oxygen, nitrogen and sulfur; R5 is hydrogen, alkyl, alkenyl, alkyl(heterocyclo), alkyl-NHCO(alkyl), alkyl-NHCO(aryl), alkyl-NHCO(heterocyclo), alkyl-NHCO(alkylheterocyclo); and n is an integer of 0 to 2. These compounds have been found to be useful in the treatment of arrhythmia.(FR) L'invention concerne des dérivés de la formule (I), dans laquelle: R1 représente halo, alkyle, alcényle, alkynyle, cycloalkyle, aryle, (aryl)alcényle, (aryl)alkynyle, alcoxy, O-alcényle, O-aryle, O-alkyle(hétérocyclo), COO-alkyle, alcanoyle, CO-amino, CO-amino substitué, alkyl-CO-amino, alkyl-CO-amino substitué, NHCO-alkyle, NHCO-aryle, NHCO-alkyl(hétérocyclo), N(alkyl)CO-alkyle, N(alkyl)CO-aryle, N(alkyl)CO-hétérocyclo, N(alkyl)CO-alkyl(hétérocyclo); R2 représente hydrogène, alkyle, halo, aryle, alcoxy, amino, amino substitué; R3 représente oxo, hydroxy, alcoxy, O-COalkyle, -O-COaryle, -O-COhétérocyclo, NOH, NO-alkyle, N-amino, N-amino substitué, N-NHCONHalkyle, N-NHSO2alkyle, N-NHSO2aryle, amino, amino substitué, NHCO-alkyle, NHCO-aryle, NHCO-hétérocyclo, spirohétérocyclo; R4 représente hydrogène, alkyle, alkyl(COalkyle), alkyl(COOalkyle); ou bien R3 et R4 pris ensemble forment avec les atomes auxquels ils sont fixés un cycle comportant cinq à sept éléments et pouvant contenir jusqu'à trois hétéroatomes choisis parmi oxygène, azote et soufre; R5 représente hydrogène, alkyle, alcényle, alkyl(hétérocyclo), alkyl-NHCO(alkyle), alkyl-NHCO(aryle), alkyl-NHCO(hétérocyclo), alkyl-NHCO(alkylhétérocyclo); et n est un nombre entier pouvant aller de 0 à 2. Lesdits composés se sont montrés utiles dans le traitement de l'arythmie.
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺